Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Other Non-Current Liabilities: 2013-2018

Historic Other Non-Current Liabilities for Soleno Therapeutics (SLNO) over the last 5 years, with Dec 2018 value amounting to $5.6 million.

  • Soleno Therapeutics' Other Non-Current Liabilities rose 6.97% to $6.1 million in Q3 2019 from the same period last year, while for Sep 2019 it was $6.1 million, marking a year-over-year increase of 6.97%. This contributed to the annual value of $5.6 million for FY2018, which is 11.16% up from last year.
  • Per Soleno Therapeutics' latest filing, its Other Non-Current Liabilities stood at $5.6 million for FY2018, which was up 11.16% from $5.1 million recorded in FY2017.
  • Soleno Therapeutics' 5-year Other Non-Current Liabilities high stood at $5.6 million for FY2018, and its period low was $61,739 during FY2016.
  • In the last 3 years, Soleno Therapeutics' Other Non-Current Liabilities had a median value of $5.1 million in 2017 and averaged $3.6 million.
  • In the last 5 years, Soleno Therapeutics' Other Non-Current Liabilities crashed by 43.57% in 2016 and then spiked by 8,131.43% in 2017.
  • Soleno Therapeutics' Other Non-Current Liabilities (Yearly) stood at $109,404 in 2015, then tumbled by 43.57% to $61,739 in 2016, then soared by 8,131.43% to $5.1 million in 2017, then grew by 11.16% to $5.6 million in 2018.